SAF312 for Chronic Pain
This study is evaluating whether a drug may help people with chronic inflammation of the cornea.
See full descriptionAbout the trial for Chronic Pain
Treatment Groups
This trial involves 3 different treatments. SAF312 is the primary treatment being studied. Participants will be divided into 2 treatment groups. Some patients will receive a placebo treatment. The treatments being tested are in Phase 2 and have already been tested with other people.
About The Treatment
Side Effect Profile for SAF312
Eligibility
This trial is for patients born any sex aged 18 and older. There are 6 eligibility criteria to participate in this trial as listed below.
Approximate Timelines
Measurement Requirements
This trial is evaluating whether SAF312 will improve 1 primary outcome and 9 secondary outcomes in patients with Chronic Pain. Measurement will happen over the course of Baseline, Week 12.
Patient Q & A Section
What causes chronic pain?
The aetiology of [chronic pain](https://www.withpower.com/clinical-trials/chronic-pain) can be divided into a number of factors, including pain perception, a biopsychosocial model and the contribution of environmental factors. The identification of such factors and effective application of scientific understanding offers promise for future treatment of chronic pain.
What are the signs of chronic pain?
This paper examines the main chronic pain syndromes and defines and discusses the various sensory and motor phenomena associated with chronic pain. Copyright © 2015 The Authors. Chronic Pain 2(4): e364-e378.
Can chronic pain be cured?
The long-term prognosis is very poor in patients with chronic low back pain treated in general practice. The overall outcome in patients treated with NSAIDs for chronic low back pain is better after three or more months of treatment than after a shorter one. The long-term prognosis of these patients is worse than in the general population, but also poorer than in those with high-quality care.
How many people get chronic pain a year in the United States?
In the United States, almost 15 million people have a disabling chronic pain problem on any given day. Chronic pain can have significant impacts on an individual's daily life. Understanding the burden on individuals with disabling chronic pain may allow us to develop better treatment strategies for such disorders.
What is chronic pain?
Chronic pain is a complex and often neglected health problem. Over half the world's population suffer from chronic pain. Most patients consider pain and their consequences as one of the most important health priorities. Chronic pain is the second most important disease burden and major risk factor for a poorer quality of life worldwide. It may induce and sustain several types of long-term consequences.
What are common treatments for chronic pain?
Most patients suffering from [chronic pain](https://www.withpower.com/clinical-trials/chronic-pain) are treated with analgesics. Non-opioid analgesics are recommended as first line treatment. Opiate and NSAIDS are also considered for management of moderate to severe pain. Acetaminophen is considered for management of mild to moderate pain. CBT and relaxation or meditation exercises are common treatments for chronic pain. Medication are considered less effective for management of pain than are other treatments.\n
How serious can chronic pain be?
Chronic pain can be very frustrating, emotionally and physically demanding, disabling and is often overlooked. A major problem associated with chronic pain is it often persists for many years before definitive treatment. In addition, chronic pain patients are often under-recognised and undertreated. Thus, patients with chronic pain should be referred with urgency to specialist care. It has been confirmed that treatment is very successful for patients who receive proper treatment. Furthermore, the impact the pain has on quality of life is immense. I think it's time to stop the debate about the seriousness of chronic pain and go for more aggressive treatment as this condition can have debilitating effects on patients.
What is the average age someone gets chronic pain?
According to the Bureau of Labor Statistics (BLS), an estimated 1.2% of all workers engage in paid work tasks that require the use of their bodies. For over 13 million workers age 15 and up, work imposes a constant reminder that their bodies are constantly being used through the activities required to perform daily tasks, especially in the hospitality industry. Over 10 million jobs are considered “heavy work,” the largest being those requiring the use of the upper body, including jobs that require repetitive work activities or lifting. Based on this data, pain is present in an estimated 1 out of every 10 work-related conditions. An estimated 1.6 trillion pounds of goods and services are required to provide consumer services in the U.S.
Has saf312 proven to be more effective than a placebo?
Given an optimal dosing interval of one week, Saf312 is more effective and is well liked than a placebo. Considering safety, tolerability, and compliance are key factors for a tolerable and acceptable product for [chronic pain](https://www.withpower.com/clinical-trials/chronic-pain) conditions, Saf312 is well positioned to achieve success.\nquestion: Does combination of anti-inflammatory and analgesic medications improve subjective and objective measures of pain and function in patients with chronic musculoskeletal pain? answer: In patients with chronic musculoskeletal pain, there was no difference in pain and functional disability when anti-inflammatory and analgesic medications were used alone versus when used together. The efficacy of the combined treatment strategy was significantly greater than that of the single medication treatments.
Who should consider clinical trials for chronic pain?
Clinical trials can be an important tool within the healthcare system for determining the effectiveness of pharmacological interventions for the treatment of chronic pain. However, our survey emphasizes that it is important that healthcare professionals become more aware of the limitations and potential consequences of the use of clinical trials when prescribing medications for the treatment of chronic pain.
Is saf312 safe for people?
Saf312 is absorbed from the intestine with a T(max) (0.75 h) and has a steady-state half-life of 12 hours, and is a potent anti-inflammatory and analgesic agent at doses of up to 60 mg BID. No clinically significant interaction between either dose or the fasting/fed state was recorded.
What is the primary cause of chronic pain?
Chronic pain, like all long-term conditions have multiple causes. We suggest multiple theories to explain the diverse causes of chronic pain: \n1. Sensory factors: (1) lack of peripheral sensory sensitivity, (2) central sensitization.\n2. Adaptive disturbances in the peripheral and central nervous system resulting in a state of hyperarousal.\n3. Peripheral or central sensitization or persistent modulation of nociceptors resulting in central sensitization.\n4. Dysfunctional input integration in association with chronic pain.\n5. Defect in descending inhibition.